Evaluation Study of Tigorazan Tablets Based on"Rapid Guidelines for Drug Evaluation and Selection in Chinese Medical Institutions"
Objective:A new oral potassium competitive acid blocker,Tigorazantablets,was evaluated to provide reference for medical institutions to select this drug.Methods:The evaluation dimension,evaluation rules and evaluation methods of the Rapid Guide for Drug Evaluation and Selection in Chinese Medical Institutions(second edition)(hereinafter referred to as the"Guide")were used to evaluate Tigorazan tablets.Results:Based on the Guide,the overall rating of Tigorasan tablets was 64.95.Among them,26 points were scored for pharmaceutical properties,18 points for effectiveness,13 points for safety,3.05 points for economy,and 4.9 points for others.Conclusion:If the medical institution does not have alternative drugs,it is weakly recommended;Alternatives are not recommended.The"Guide"can help medical institutions to evaluate and select drugs quickly,and it can provide guidance and reference for medication use in medical institutions.
Novel potassium competitive acid blockersTegoprazanDrug evaluationDrug selectionRapid guide for drug evalua-tion and selection in medical institutions in China
国家科技期刊平台
NSTL
万方数据
